0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > CD138

CD138

Brief Information

Name:Syndecan-1
Target Synonym:Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CART-138 (Chinese PLA General Hospital) Phase 2 Clinical Pla General Hospital Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms Details
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) Phase 1 Clinical Unc Lineberger Comprehensive Cancer Center Multiple Myeloma; Immune System Diseases Details
CART-138 (Chinese PLA General Hospital) Phase 2 Clinical Pla General Hospital Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms Details
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) Phase 1 Clinical Unc Lineberger Comprehensive Cancer Center Multiple Myeloma; Immune System Diseases Details

This web search service is supported by Google Inc.

totop

Nachricht schicken